Abstract
Objectives
Calcitonin gene-related peptide (CGRP) is a smooth muscle relaxant with potent vasodilating properties. To investigate its inhibitory effects on human myometrial contractions, we obtained excised human myometria from term pregnant, with and without spontaneous labor, and nonpregnant patients.
Methods
Myometrial strips were mounted in tissue baths in which contractile activity was recorded. Spontaneously contracting tissues in vitro were exposed to increasing concentrations of CGRP (10−11-10−7 mol/L). Tissues without spontaneous contractions were induced to contract with either oxytocin or KCl before being exposed to CGRP. The IC25 (CGRP concentration required to inhibit contractility by 25%) was used as comparison between groups.
Results
Tissues with spontaneous or oxytocin-induced in vitro contractions responded equally to CGRP relaxation. Tissues induced to contract with KCl in vitro required approximately 2000 times more CGRP for equal relaxation. In tissues with spontaneous or oxytocin-induced in vitro contractions, those from pregnant unlabored patients were 60 times more sensitive to CGRP than those from pregnant labored or nonpregnant patients. The latter two groups responded equally to CGRP.
Conclusions
The sensitivity of myometrial tissues to CGRP relaxation in vitro is increased from the nonpregnant to the pregnant term state. This increased sensitivity is lost once patients develop spontaneous term labor. The relative ineffectiveness of CGRP in relaxing KCl-induced in vitro contractions probably reflects its known mechanism of action, namely the hyperpolarization of cell membrane potentials via activation of membrane potassium channels.
Similar content being viewed by others
References
Garfield RE. Gap junction formation in the myometrium: Control by estrogen, progesterone, and prostaglandin. Am J Physiol 1980;238:C81–9.
Fuchs AR, Fuchs F, Husslein P, Solof MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984;150:734–41.
Thorbert G. Regional changes in structure and function of adrenergic neurons in guinea pig uterus during pregnancy. Acta Obstet Gynecol Scand 1979;(suppl 79):5–21.
Wikland M, Lindblom B, Dahlström A, Haglid KG. Structural and functional evidence tor degeneration of human myometrium during pregnancy. Obstet Gynecol 1984;64:503–9.
Sladek SM, Regenstein AC, Lykins D, Roberts JM. Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol 1993;169:1285–91.
Buhimschi I, Yallampalli C, Dong YL, Garfield RE. Involvement of a nitric oxide—cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995;172:1577–84.
Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982;298:240–4.
Brain SP, Williams TJ, Tippins JR, Morris HR, MacInryre I. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985;313:54–6.
Transforini G, Margutti A, Portaluppi E, et al. Circadian profile of calcitonin gene—related peptide in healthy man. J Clin Endocrinol Metab 1991;73:943–51.
Nelson MT, Yu H, Brayden JE, Heschler J, Standen NB. Arterial dilations in response to calcitonin gene—related peptide involve activation of K+ channels. Nature 1990;344:770–3.
McCulloch J, Uddman R, Kingman TA, Edvinson L. Calcitonin gene-related peptide: Functional role in cerebrovascular regulation. Proc Natl Acad Sci USA 1986;83:5731–5.
Kim D. Calcitonin gene—related peptide activates the muscarinic-gated K+ current in atrial cells. Pfeüger Arch 1991;418:338–45.
Lenz HJ, Motrud MT, Vale WW, River JE, Brown MR. Calcitonin gene-related peptide acts within the central nervous system to inhibit gastric acid secretion. Regul Pept 1984;9:271–7.
Gibson SJ, Polak JM, Bloom SR, et al. Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci 1984;4:3101–11.
Fontaine B, Klarsfeld A, Hökfeld T, Changeux JP. Calcitonin gene-related peptide, a peptide present in spinal cord motor neurons, increases the number of acetylcholine receptors in primary cultures of chick embryo myotubes. Neurosci Lett 1986;71:59–65.
Wimalawansa SJ, Morris HR, MacIntyre I. Both α- and β-calcitonin gene-related peptides are present in plasma, cerebrospinal fluid and spinal cord in man. J Mol Endocrinol 1989;3:247–52.
Gibbins IL, Wattchow D, Coventry B. Two immunohistochem-ically identified populations of calcitonin gene-related peptide (CGRP)-immunoreactive axons in human skin. Brain Res 1985;414:143–8.
Mora M, Marchi M, Polak JM, Gibson SJ, Cornelio F. Calcitonin gene—related peptide immunoreactivity at the human neuromuscular junction. Brain Res 1989;492:404–7.
Samuelson UE, Dalsgaard C, Lungberg JM, Hökfelt T. Calcitonin gene-related peptide inhibits spontaneous contractions in human uterus and fallopian tube. Neurosci Lett 1985;62:225–30.
Pennefather JN, Reynoldson NA, Handburg GM. Inhibition of rat uterine contractions by rat and human CGRP. Peptides 1990;11:903–6.
Shew RL, Papka RE, McNeill DL, Yee JA. NADPH-diaphorase-positive nerves and the role of nitric oxide in CGRP relaxation of uterine contraction. Peptides 1993;14:637–41.
Shew RL, Papka RE, McNeill DL. Substance P and calcitonin gene-related peptide immunoreactivity in nerves of the rat uterus: Localization, co-localization and effects on uterine contractility. Peptides 1991;12:593–600.
Shew RL, Papka RE, McNeill DL. Galanin and calcitonin gene-related peptide immunoreactivity in nerves of the rat uterus: Localization, co-localization and effects on uterine contractility. Peptides 1992;13:273–9.
Reynoldson N, Pennefather GM, Handburg GM, Ziccone SP, Pauli JD. The effects of human calcitonin gene-related peptide on myometrial preparations from pregnant and non-pregnant women. American Society of Chemical and Experimental Pharmacology. Abstract 187, 1989.
Saggese G, Bertelloni S, Baroncelli GI, Pelletti A, Benedetti U. Evaluation of a peptide family encoded by the calcitonin gene in selected healthy pregnant women. Horm Res 1990;34:240–4.
Stevenson JC, MacDonald DWR, Warren RC, Booker MW, Whitehead MI. Increased concentration of circulating calcitonin gene-related peptide during normal human pregnancy. Br Med J 1986;293:1329–30.
Taquet H, Uzan S. Plasma calcitonin gene-related peptide during gestation. Lancet 1992;340:1170.
Tritthart HA, Mahnert W, Fleischhacker N, Adelwöhrer N. Potassium channels and modulating factors of channel functions in the human myometrium. Z Kardiol 1991;80(suppl. 7):29–33.
Kageyama M, Yanagisawa T, Taiga N. Calcitonin gene-related peptide relaxes porcine coronary arteries via cyclic AMP-dependent mechanisms, but not activation of ATP-sensitive po tassium channels. J Pharm Exp Ther 1993;265:490–7.
Author information
Authors and Affiliations
Additional information
Supported by the Birthright Foundation through the 1992–1993 American College/Royal College of Obstetricians and Gynaecologists Birthright Research Fellowship.
Rights and permissions
About this article
Cite this article
Chan, K.K.H., Robinson, G. & Pipkin, F.B. Differential Sensitivity of Human Nonpregnant and Pregnant Myometrium to Calcitonin Gene-Related Peptide. Reprod. Sci. 4, 15–21 (1997). https://doi.org/10.1016/S1071-5576(96)00058-5
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1071-5576(96)00058-5